Optimal price rules, administered prices and suboptimal prevention: Evidence from a Medicare program

Journal of Regulatory Economics

Volumn 25, Issue 1, 2004, Pages 81-104

  Dor, Avi ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Medicare; Prevention; Price regulation; Pricing

Indexed keywords

EID: 4043170598     PISSN: 0922680X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:REGE.0000008656.82249.3a     Document Type: Article

References (51)

1. Angrist, J. D. 2001. "Estimation of Limited Dependent Variable Models With Dummy Endogenous Regressions: Simple Strategies for Empirical Practice." Journal of Business and Economic Statistics 19(1): 2-15.
2. Atkinson, A. B., and J. E. Stiglitz. 1980. Lectures on Public Economics. London: McGraw-Hill.
3. Baumol, W. J., and D. F. Bradford. 1970. "Optimal Departures from Marginal Cost Pricing." American Economic Review 60(3): 265-283.
4. Barnett, A. H., T. R. Beard, and D. L. Kasserman. 1993. "Inefficient Pricing Can Kill: The Case of Dialysis Industry Regulation." Southern Economic Journal 60(2): 393-404.
5. Blundell, R. W., and R. J. Smith. 1989. "Estimation in a Class of Simultaneous Equation Limited Dependent Variable Models." Review of Economic Studies 56(1): 37-57.
6. Collins, A. J., J. Z. Ma, A. Umen, and P. Keshaviah. 1994. "Urea Index and Other Predictors of Hemodialysis Patient Survival." Americam Journal of Kidney Diseases 23(2): 272-282.
7. Cromwell, J., D. A. Dayhoff, and A. H. Thoumaian. 1997. "Cost Savings and Physician Responses to Global Payments for Medicare Heart Bypass Surgery." Health Care Financing Review 19(1): 41-57.
8. Cutler, D. M. 1995. "The Incidence of Adverse Medical Outcomes under Prospective Payment." Econometrica 63(1): 29-50.
9. Daugirdas, J. T., and T. Ing. 1994. Handbook of Dialysis. Boston, MA: Little, Brown, and Company.
10. Department of Health and Human Services. 1989. The Surgeon General's Report on Health Promotion and Disease Prevention. Washington, DC: Government Printing Office.
11. Dor, A., P. J. Held, and M. V. Pauly. 1992. "The Medicare Cost of Renal Dialysis: Evidence from a Statistical Cost Function." Medical Care 30(10): 879-891.
12. Dor, A., and H. Watson. 1995. "The Hospital Physician Interaction in U.S. Hospitals: Evolving Payments Schemes and Their Incentives." European Economic Review 39(3): 795-802.
13. Ehrlich, L., and G. S. Becker. 1972. "Market Insurance, Self-Insurance, and Self-Protection." Journal of Political Economy 80(4): 623-648.
14. Ellis, R. P. 1998. "Creaming, Skimping and Dumping: Provider Competition on the Intensive and Extensive Margins." Journal of Health Economics 17(5): 537-555.
15. Farley, D. O., G. M. Carter, J. D. Kallich, T. W. Lucas, and K. L. Spritzer. 1996. "Modified Capitation and Treatment Incentives for End Stage Renal Disease." Health Care Financing Review 17(3): 129-142.
16. Gotch, F. A., and J. A. Sargent. 1985. "A Mechanistic Analysis of the National Cooperative Dialysis Study." Kidney International 28(3): 526-534.
17. Greene, W. H. 1997. Econometric Analysis. Prentice Hall (3rd edition).
18. Hakim, R. M., J. Breyer, N. Ismail, and G. Schulman. 1994. "Effects of Dose of Dialysis on Morbidity and Mortality." American Journal of Kidney Diseases 23(5): 661-669.
19. Health Care Financing Administration. 1998. ESRD Core Indicators Project: Initial Results. Baltimore, MD: Health Care Financing Administration (December).
20. Held, P. J., F. K. Port, R. A. Wolfe, D. C. Stannard, C. E. Carroll, J. T. Daugirdas, W. E. Bloembergen, J. W. Greer, and R. M. Hakim. 1996. "The Dose of Hemodialysis and Patient Mortality." Kidney International 50(2): 550-556.
21. Helgerson, S. D., W. M. McCllelan, and P. R. Frederick et al. 1997. "Improvement in Adequacy of Delivered Dialysis for In-Center Adult Hemodialysis Patients in the United States, 1993 to 1995." American Journal of Kidney Diseases 29(6): 851-861.
22. Herring, B. 1999. "Provision of Preventive Care in Markets with Consumer Switching Among Insurers: Evidence from Mammography." Leonard Davis Institute of Health Economics, University of Pennsylvania, working paper.
23. Hirth, R. A., P. J. Held, S. M. Orzol, and A. Dor. 1999. "Practice Patterns, Case Mix, Medicare Payment Policy, and Dialysis Costs." Health Services Research 33(6): 1567-1592.
24. Hull, A. R. 1992. "Impact of Reimbursement Regulations on Patient Management." American Journal of Kidney Disease 20(1, suppl 1): 8-11.
25. Kenkel, D. S. 2000. "Prevention." In Handbook of Health Economics, vol 1b, edited by A. J. Culyer, and J. P. Newhouse, Elsevier Sciences, B: Amsterdam, Ch. 31, pp. 1685-1693.
26. Iglehart, J. K. 1993. "The American Health Care System: The End Stage Renal Disease Program." New England Journal of Medicine 328(5): 366-371.
27. Long, J. S. 1997. Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, CA: Sage Publications.
28. Maiorca, R., G. Brunori, R. Zubani, G. C. Cancarini, L. Manili, C. Camerini, E. Movilli, A. Pola, G. d'Avolio, and U. Gelatti. 1995. "Predictive Value of Dialysis Adequacy and Nutritional Indices for Mortality and Morbidity in CAPD and HD Patients: A Longitudinal Study." Nephrology Dialysis Transplantation 10(12): 2295-2305.
29. Manning, W. G. 1998. "The Logged Dependent Variable, Heteroscedasticity, and the Retransformation Problem." Journal of Health Economics 17(3): 283-295.
30. McCllelan, W. M., D. L. Frankenfield, P. R. Fredrick et al. 1999. "Can Dialysis Therapy Be Improved? A Report from the ESRD Core Indicators Project." American Journal of Kidney Diseases 34(6): 1075-1082.
31. McCullough, K. P., E. W. Young, B. J. Canaud, R. A. Wolfe, F. K. Port, P. J. Held. 2000. "Delivered Dialysis Dose Predicts Mortality for Hemodialysis Patients in the U.S. and Europe." Journal of the American Society of Nephrology 11(suppl): 325A.
32. Medicare Payment Advisory Commission (MEDPAC). 1999. Health Care Spending and the Medicare Program: A Data Book. Washington, DC: MedPAC (July).
33. Medicare Payment Advisory Commission (MEDPAC). 2000. Selected Medicare Issues: A Data Book. Washington, DC: MedPAC (June).
34. Miller, M. E., and W P. Welch. 1992. "Physician Charges in the Hospital: Exploring Episodes of Care for Controlling Volume Growth." Medical Care 30(7): 630-645.
35. Mullahy, J. 1998. "Much Ado About Two: Reconsidering the Retransforamtion and the Two-part Model in Health Econometrics." Journal of Health Economics 17(3): 247-281.
36. National Institutes of Health. 1999. U.S. Renal Data System: 1999 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Kidney Diseases.
37. Nordquist, G., and S. Y. Wu. 1976. "The Joint Demand for Health Insurance and Preventive Medicine." In The Role of Health Insurance in the Health Services Sector, edited by R. Rosett, New York, NY: National Bureau of Economic Research.
38. Owen, W. F. Jr., N. L. Lew, Y. Liu, E. G. Lowrie, and J. M. Lazarus. 1993. "The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis." New England Journal of Medicine 329(14): 1001-1006.
39. Owen, W. F. E., G. M. Chertew, J. M. Lazarus, and E. G. Lowrie. 1998. "Dose of Hemodialysis and Survival." Journal of the American Medical Association 280(20): 1764-1768.
40. Parker, T., L. Husni, W. Huang, N. Lew, E. Lowrie. 1994. "Survival of Hemodialysis Patients in the United States is Improved with a Greater Quantity of Dialysis." American Journal of Kidney Disease 23(5): 670-680
41. Pauly, M. V. 1974. "Overinsurance and Public Provision of Insurance: The Roles of Moral Hazard and Adverse Selection." Quarterly Journal of Economics 88(1): 44-62.
42. Rizzo, J. A., and J. L. Sindelar. 1996. "Optimal Regulation of Multiply-Regulated Industries: The Case of Physician Services." Southern Economic Journal 62(4): 966-978.
43. Russell, L. B. 1986. Is Prevention Better Than Cure? Washington, DC: Brookings Institution Press.
44. Schlesinger, H., and E. Venezian. 1986. "Insurance Markets with Loss-Prevention Activity: Profits, Market Structure, and Consumer Welfare." Rand Journal of Economics 17(2): 227-238.
45. Sehgal, A. R., A. Dor, and A. C. Tsai. 2001. "Morbidity and Cost Implications of Inadequate Hemodialysis." American Journal of Kidney Diseases 37(6): 1223-1231.
46. Sehgal, A. R., J. B. Leon, L. A. Siminoff, M. E. Singer, L. M. Bunosky, and R. D. Cebul. 2002. "Improving the Quality Hemodialysis Treatment: A Community-Based Randomized controled Trial to Overcome Patient-Specific Barriers." Journal of the American Medical Association 287(15): 1961-1967.
47. Sehgal, A. R., R. J. Snow, M. E. Singer, S. B. Amini, P. B. DeOreo, M. R. Silver, and R. D. Cebul. 1998. "Barriers to Adequate Delivery of Hemodialysis." American Journal of Kidney Diseases 31(4): 593-601.
48. Selden, T. M. 1990. "A Model of Capitation." Journal of Health Economics 9(4): 379-409.
49. Sheshinski, E. 1986. "Positive Second-Best Theory; A Brief Survey of the Theory of Ramsey Pricing." In Handbook of Mathematical Economics. Vol. 3, edited by K. Arrow, and M. Intriligator, Amsterdam: Elsevier.
50. Smith, R. J., and R. W. Blundell. 1986. "An Exogeneity Test for a Simultaneous Equation Tobit Model with an Application to Labor Supply." Econometrica 54(3): 679-685.
51. Tirole, J. 1989. The Theory of Industrial Organization. Cambridge Massachusetts: MIT Press.